Printer Friendly

New generic drugs on the way?

Some significant brand-name drugs lost (or are scheduled to lose) their patents in 2002 and 2003. This will open the door for generic drug launches of the same medications.

Drugs with significant potential that are having generic equivalents hit the market are: Ortho-Novum 7/7/7 * (birth control) Ortho Tri-Clyclen * (birth control) Accupril (blood pressure) Nolvadex (breast cancer) Topamax (anti-convulsant) Glucophage XR (diabetes) Monopril (blood pressure) Remeron (antidepressant) Alphagan (glaucoma) Serzone (antidepressant) Glucovance (diabetes) Glucotrol XL (diabetes) Wellbutrin SR (antidepressant) Zyban (smoking cessation) Neurontin (anti-convulsant) Tiazac (blood pressure) Prozac (antidepressant) Prilosec (gastritis)

* Indicates approval, but has not been marketed as a generic drug as patent issues remain.

Special Note:

This list is a good-faith effort to provide useful information on innovative drug products that face potential competition from a generic equivalent. Many of the drugs listed are associated with active patents that have been challenged. Resolution of these patent challenges in favor of the generic drug maker likely will determine if a generic can be approved in the year noted. For this reason, some of the drugs listed likely will not face generic competition as shown. The expiration of the pediatric exclusivity has been considered for some of the listed drugs. The list is not static and is constantly updated.
COPYRIGHT 2003 Journal Publishing, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Arkansas Business
Article Type:Brief Article
Geographic Code:1USA
Date:Aug 18, 2003
Words:210
Previous Article:Pill-packaging and advertising: understanding the cost of new drugs.
Next Article:On-line resources for health and prescription drug information.
Topics:


Related Articles
Questions and answers on generic drugs.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters